Stylus Medicine Launches to Develop Precision, In Vivo Genetic Medicines and Unlock the Full Potential of CAR-T Therapy
─ $85 million in financing includes recent $45 million Series A extension with participation from founding investors RA Capital Management and Khosla Ventures and six new investors including biopharmaceutical company venture funds Chugai Venture Fund,…